drugset / Trial / NCT00003946

Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer

NCT00003946

Treatment

Summary

RATIONALE: Hormone therapy may be an effective treatment for endometrial cancer. PURPOSE: Phase II trial to study the effectiveness of danazol in treating patients with advanced or recurrent endometrial cancer.

Timeline

Start
1999-08
Primary completion
2003-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Danazol Other / unclassified 100 mg Oral

Indications